Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current PerspectivesReview Published on 2023-10-062024-09-04 Journal: Molecular pharmacology [Category] 대상포진, [키워드] disease-modifying antirheumatic drug DMARD JAKi Janus kinase inhibitors RA selectivity [DOI] 10.2147/PPA.S417677 PMC 바로가기 [Article Type] Review
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 studyClinical Science Published on 2023-06-252024-09-04 Journal: Rheumatology (Oxford, England) [Category] 대상포진, [키워드] biologic agent DMARD IL-23 PSA risankizumab [DOI] 10.1093/rheumatology/keac605 PMC 바로가기 [Article Type] Clinical Science
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 studyClinical Science Published on 2023-06-252024-09-04 Journal: Rheumatology (Oxford, England) [Category] 대상포진, [키워드] biologic agent DMARD IL-23 PSA risankizumab [DOI] 10.1093/rheumatology/keac607 PMC 바로가기 [Article Type] Clinical Science
Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and designarticle Published on 2022-12-262024-09-02 Journal: BMC Rheumatology [Category] 대상포진, [키워드] biologics DMARD Elderly onset frailty MTX Patient and public involvement Prospective Study [DOI] 10.1186/s41927-022-00322-7 PMC 바로가기 [Article Type] article
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations류마티스성 근골격계 질환의 면역억제제 치료는 SARS-CoV-2 감염에 대한 체액 반응의 유발을 억제하지 않고 이펙터 면역 세포 집단을 보존합니다Article Published on 2022-06-102022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료법, [키워드] adaptive addition affected Analysis antibody Antibody Response Antibody responses Arthritis B lymphocytes biologic carried Cellular immune response COVID-19 CTLA4 disease disease-modifying anti-rheumatic drug Disease-modifying anti-rheumatic drugs Diseases DMARD drug effector elicit functional humoral Humoral and cellular immune responses immune immune cell populations immune response immune responses immune system immunological Immunosuppressant include individual Inflammatory Inflammatory arthritis inhibitor inhibitors life-threatening Musculoskeletal Neutralizing activity Pathologies Patient patients treated Population presenting provide RBD protein RBD proteins Re-infections response rheumatic musculoskeletal diseases. SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleocapsid sustained the antibody response TNF-α Treatment virus [DOI] 10.3389/fimmu.2022.873195 PMC 바로가기 [Article Type] Article
Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needsSupplement Papers Published on 2021-11-242024-09-04 Journal: Rheumatology (Oxford, England) [Category] 대상포진, [키워드] bDMARD clinical trial csDMARD DMARD Remission rheumatoid arthritis Safety Treatment tsDMARD [DOI] 10.1093/rheumatology/keab609 PMC 바로가기 [Article Type] Supplement Papers
Complications of COVID-19 Pneumonia and Multiple Sclerosis ExacerbationFamily/General Practice Published on 2021-08-272022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Autoimmune disease average Brain Complication coronavirus disease COVID COVID-19 COVID-19 pneumonia Demyelination disrupt DMARD Exacerbation Hospitalization immunological increased risk Infection inpatient admission Limited MS Multiple multiple sclerosis multiple sclerosis exacerbation multiple sclerosis flare-ups Neurological symptom occur Patient Pneumonia Relapsing-Remitting Multiple Sclerosis reported sclerosis severe COVID-19 shown steroid Stress subgroups Symptom management the disease The United States Transmission Treatment while worsened [DOI] 10.7759/cureus.17506 PMC 바로가기 [Article Type] Family/General Practice
Managing rheumatic diseases during COVID-19Review Article Published on 2020-09-082023-07-02 Journal: Clinical Rheumatology [Category] SARS, [키워드] Autoimmune COVID-19 DMARD immunosuppressive medications rheumatic [DOI] 10.1007/s10067-020-05387-8 PMC 바로가기 [Article Type] Review Article
Rheumatoid arthritisReview Published on 2020-09-072024-09-02 Journal: Inflammation and Regeneration [Category] 대상포진, [키워드] Biological Diagnosis DMARD rheumatoid arthritis Treatment [DOI] 10.1186/s41232-020-00133-8 PMC 바로가기 [Article Type] Review
African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemicOriginal Article Published on 2020-09-022022-10-31 Journal: Clinical Rheumatology [Category] COVID-19, SARS, [키워드] African African rheumatology Against breast milk Clinical practice conducted COVID-19 COVID-19 pandemic criteria develop disease disease-modifying anti-rheumatic drug DMARD Evidence Infection initial management moderate Musculoskeletal objective Patient Point positive processed Prophylaxis question recommendation recommendations reduced Region representing Result Rheumatic and musculoskeletal diseases rheumatic disease rheumatism rheumatologist rheumatology SARS-CoV-2 Spread stratified subgroup subgroups transmitted Treatment [DOI] 10.1007/s10067-020-05355-2 PMC 바로가기 [Article Type] Original Article